Mbx Biosciences
Clinical trials sponsored by Mbx Biosciences, explained in plain language.
-
New obesity drug MBX 4291 enters first human safety trial
Disease control Recruiting nowThis early-stage study tests a new drug called MBX 4291 in 124 adults with obesity (BMI 30 to under 50). The main goal is to see if the drug is safe and how well people tolerate it. Participants receive either the drug or a placebo as an injection under the skin. The study is cur…
Phase: PHASE1 • Sponsor: MBX Biosciences • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New shot aims to stop dangerous sugar crashes after gastric bypass
Symptom relief Recruiting nowThis study tests an experimental drug called MBX 1416 for people who have dangerously low blood sugar after weight-loss surgery. Ten adults who had gastric bypass or sleeve gastrectomy at least a year ago will receive a single injection of the drug. Researchers will measure how w…
Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Symptom relief
Last updated May 26, 2026 06:50 UTC